Source: Bmc medicine. Unidade: FM
Subjects: FIBRILAÇÃO ATRIAL, COGNIÇÃO
ABNT
CARAMELLI, Bruno et al. Effects of dabigatran versus warfarin on 2-year cognitive outcomes in old patients with atrial fibrillation: results from the GIRAF randomized clinical trial. Bmc medicine, v. 20, n. 1, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50442. Acesso em: 04 nov. 2024.APA
Caramelli, B., Yu, P. C., Cardozo, F. A. M., Magalhaes, I. R., Spera, R. R., Amado, D. K., et al. (2022). Effects of dabigatran versus warfarin on 2-year cognitive outcomes in old patients with atrial fibrillation: results from the GIRAF randomized clinical trial. Bmc medicine, 20( 1). doi:10.1186/s12916-022-02563-2NLM
Caramelli B, Yu PC, Cardozo FAM, Magalhaes IR, Spera RR, Amado DK, Escalante-rojas MC, Gualandro DM, Calderaro D, Tavares CAM. Effects of dabigatran versus warfarin on 2-year cognitive outcomes in old patients with atrial fibrillation: results from the GIRAF randomized clinical trial [Internet]. Bmc medicine. 2022 ; 20( 1):[citado 2024 nov. 04 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50442Vancouver
Caramelli B, Yu PC, Cardozo FAM, Magalhaes IR, Spera RR, Amado DK, Escalante-rojas MC, Gualandro DM, Calderaro D, Tavares CAM. Effects of dabigatran versus warfarin on 2-year cognitive outcomes in old patients with atrial fibrillation: results from the GIRAF randomized clinical trial [Internet]. Bmc medicine. 2022 ; 20( 1):[citado 2024 nov. 04 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50442